Galmed Pharmaceuticals Ltd.

NasdaqCM:GLMD 株式レポート

時価総額:US$4.9m

Galmed Pharmaceuticals マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Allen Baharaff

最高経営責任者

US$1.4m

報酬総額

CEO給与比率40.6%
CEO在任期間24.8yrs
CEOの所有権n/a
経営陣の平均在職期間7.7yrs
取締役会の平均在任期間8.9yrs

経営陣の近況

Recent updates

Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

May 16
Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Jan 06
Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Galmed GAAP EPS of -$0.15 beats by $0.09

Aug 04

Companies Like Galmed Pharmaceuticals (NASDAQ:GLMD) Could Be Quite Risky

May 03
Companies Like Galmed Pharmaceuticals (NASDAQ:GLMD) Could Be Quite Risky

Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Jan 15
Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

Oct 02
Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Invest In Growth?

May 20
Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Invest In Growth?

Galmed gets greenlight for late-stage Aramchol NASH trial in China

May 03

What Type Of Shareholders Own The Most Number of Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Shares?

Feb 04
What Type Of Shareholders Own The Most Number of Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Shares?

We Think Galmed Pharmaceuticals (NASDAQ:GLMD) Can Afford To Drive Business Growth

Dec 06
We Think Galmed Pharmaceuticals (NASDAQ:GLMD) Can Afford To Drive Business Growth

Galmed EPS misses by $0.02

Nov 12

CEO報酬分析

Galmed Pharmaceuticals の収益と比較して、Allen Baharaff の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$6m

Dec 31 2023US$1mUS$551k

-US$7m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$11m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$1mUS$605k

-US$18m

Sep 30 2022n/an/a

-US$23m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$3mUS$632k

-US$32m

Sep 30 2021n/an/a

-US$35m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$32m

Dec 31 2020US$1mUS$503k

-US$29m

Sep 30 2020n/an/a

-US$27m

Jun 30 2020n/an/a

-US$24m

Mar 31 2020n/an/a

-US$23m

Dec 31 2019US$1mUS$486k

-US$20m

Sep 30 2019n/an/a

-US$16m

Jun 30 2019n/an/a

-US$12m

Mar 31 2019n/an/a

-US$11m

Dec 31 2018US$2mUS$384k

-US$10m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$12m

Mar 31 2018n/an/a

-US$12m

Dec 31 2017US$1mUS$384k

-US$12m

報酬と市場: Allenの 総報酬 ($USD 1.36M ) は、 US市場 ($USD 653.78K ) の同規模の企業の平均を上回っています。

報酬と収益: Allenの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Allen Baharaff (59 yo)

24.8yrs

在職期間

US$1,356,184

報酬

Mr. Allen Baharaff has been the Chief Executive Officer of Galmed Pharmaceuticals Ltd. since January 2012 and has been its President since March 2015. Mr. Baharaff co-founded the Galmed Pharmaceuticals Ltd...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Allen Baharaff
Co-Founder24.8yrsUS$1.36mデータなし
Doron Cohen
Chief Financial Officer2.8yrsUS$273.81k0.0011%
$ 55.2
Guy Nehemya
COO & Data Protection Officer7.7yrsUS$374.78k0.0021%
$ 100.6
Yohai Stenzler
Chief Accounting Officer2.8yrsUS$378.32k0.0021%
$ 100.6
Liat Hayardeny
Chief Scientific Officer8.2yrsUS$114.69k0%
$ 0
Tali Gorfine
Medical Consultant7.7yrsUS$382.51kデータなし

7.7yrs

平均在職期間

55.5yo

平均年齢

経験豊富な経営陣: GLMDの経営陣は経験豊富で経験豊富です(平均在職期間は7.7年)。


取締役

名称ポジション在職期間報酬所有権
Allen Baharaff
Co-Founderno dataUS$1.36mデータなし
David Sidransky
Lead Independent Director10.4yrsデータなし0.0028%
$ 136.2
Carol Brosgart
Independent Director7.4yrsデータなし0%
$ 0
José Mato de la Paz
Member of Scientific Advisory Boardno dataデータなしデータなし
Scott L. Friedman
Member of Scientific Advisory Boardno dataデータなしデータなし
Arun Sanyal
Member of Scientific Advisory Boardno dataデータなしデータなし
Vlad Ratziu
Member of Scientific Advisory Boardno dataデータなしデータなし
Shmuel Nir
Independent Director17.8yrsデータなし0.0028%
$ 136.2
Amir Poshinski
Independent Director4.4yrsデータなし0%
$ 0
Shomron Ben-Horin
Member of Scientific Advisory Boardno dataデータなしデータなし

8.9yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: GLMDの 取締役会経験豊富 であると考えられます ( 8.9年の平均在任期間)。